Artemisinin, produced in the glandular trichomes of Artemisia annua L. is a vital antimalarial drug effective against Plasmodium falciparum resistant to quinine-derived medicines. Although work has progressed on the semi-synthetic production of artemisinin, field production of A. annua remains the principal commercial source of the compound. Crop production of artemisia must be increased to meet the growing worldwide demand for artemisinin combination therapies (ACTs) to treat malaria. Grower artemisinin yields rely on plants generated from seeds from open-pollinated parents. Although selection has considerably increased plant artemisinin concentration in the past 15 years, seed-generated plants have highly variable artemisinin content that lowers artemisinin yield per hectare. Breeding efforts to produce improved F_(1)hybrids have been hampered by the inability to produce inbred lines due to self-incompatibility. An approach combining conventional hybridization and selection with clonal propagation of superior genotypes is proposed as a means to enhance crop yield and artemisinin production. Typical seed-propagated artemisia plants produce less than 1% (dry weight) artemisinin with yields below 25 kg/ha. Genotypes were identified producing high artemisinin levels of over 2% and possessing improved agronomic characteristics such as high leaf area and shoot biomass production. Field studies of clonally-propagated high-artemisinin plants verified enhanced plant uniformity and an estimated gross primary productivity of up to 70 kg/ha artemisinin, with a crop density of one plant m~(-2). Tissue culture and cutting protocols for the mass clonal propagation of A. annua were developed for shoot regeneration, rooting, acclimatization, and field cultivation. Proof of concept studies showed that both tissue culture-regenerated plants and rooted cutting performed better than plants derived from seed in terms of uniformity, yield, and consistently high artemisinin content. Use of this technology to produce plants with homogeneously-high artemisinin can help farmers markedly increase the artemisinin yield per cultivated area. This would lead to increased profit to farmers and decreased prices of ACT.
展开▼
机译:在青蒿的腺毛中产生的青蒿素是一种重要的抗疟药,对恶性疟原虫对奎宁类药物具有抗药性。尽管有关青蒿素半合成生产的工作已取得进展,但青蒿的田间生产仍是该化合物的主要商业来源。必须增加青蒿的作物产量,以满足全球对青蒿素联合疗法(ACT)治疗疟疾的日益增长的需求。种植青蒿素的产量依赖于由开放授粉的亲本种子产生的植物。尽管在过去15年中选择已大大增加了植物青蒿素的浓度,但种子产生的植物中青蒿素的含量变化很大,从而降低了每公顷青蒿素的产量。由于自身不相容性而无法产生自交系,从而阻碍了生产改良F_(1)杂种的育种努力。提出了一种将常规杂交和选择与优良基因型的克隆繁殖相结合的方法,作为提高作物产量和青蒿素产量的一种手段。典型的种子繁殖的蒿属植物产生的青蒿素少于1%(干重),单产低于25千克/公顷。鉴定出产生高青蒿素水平超过2%并具有改良的农艺特性(例如高叶面积和枝条生物量)的基因型。对无性繁殖的高青蒿素植物进行的田间研究证实,提高了植物的均匀性,估计青蒿素的总初级生产力高达70 kg / ha,单株植物密度为m〜(-2)。开发了用于A.annua大规模克隆繁殖的组织培养和切割方案,用于芽再生,生根,驯化和田间栽培。概念验证研究表明,组织培养再生植物和生根切割在均匀性,产量和始终较高的青蒿素含量方面都比种子衍生的植物更好。利用该技术生产具有较高青蒿素含量的植物可以帮助农民显着提高每耕地的青蒿素产量。这将增加农民的利润,并降低ACT的价格。
展开▼